PF-54606 |
MULTIBIC 4 MMOL/L de potasio solución para hemodiálisis y hemofiltración |
2022-11-02 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Sumedica |
Cedisa |
Clínica Médica Renal Emanuel |
Sumedica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59870 |
multiBic sin potasio solución para hemodiálisis y hemofiltración |
2026-08-16 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Cedisa |
Clínica Médica Renal Emanuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59883 |
multiBic 3 mmol/L de potasio solución para hemodiálisis y hemofiltración |
2026-08-17 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Cedisa |
Clínica Médica Renal Emanuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59948 |
multiBic 2 mmol/L de potasio solución para hemodiálisis y hemofiltración |
2026-08-31 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Cedisa |
Clínica Médica Renal Emanuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27612 |
GRANUDIAL AF 12 POLVO PARA HEMODIALISIS |
2007-05-17 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27614 |
BIBAG 650 g POLVO PARA HEMODIALISIS |
2007-05-17 |
|
Fresenius Medical Care Deutschland GmbH |
Alemania
|
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18636 |
A.N.D.Y. PLUS CAPD/DPCA-3 solucion dialisis peritoneal |
2007-07-10 |
|
Fresenius Medical Care España |
España
|
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18638 |
A.N.D.Y. PLUS CAPD/DPCA-4 solucion dialisis peritoneal |
2007-07-10 |
|
Fresenius Medical Care Deutschland GmbH |
España
|
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18639 |
A.N.D.Y. PLUS CAPD/DPCA-2 solucion dialisis peritoneal |
2007-07-10 |
|
Fresenius Medical Care España |
España
|
Agencias J.i. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-47360 |
OSVAREN 435 mg/235mg Comprimidos Recubiertos con Película |
2017-05-22 |
|
Fresenius Medical Care Nephrologica Deutschland GmbH |
Alemania
|
Agencias J.I. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|